Peripheral Neuropathy News and Research

RSS
Peripheral neuropathy describes damage to the peripheral nervous system, which transmits information from the brain and spinal cord to every other part of the body.

More than 100 types of peripheral neuropathy have been identified, each with its own characteristic set of symptoms, pattern of development, and prognosis. Impaired function and symptoms depend on the type of nerves -- motor, sensory, or autonomic -- that are damaged. Some people may experience temporary numbness, tingling, and pricking sensations, sensitivity to touch, or muscle weakness. Others may suffer more extreme symptoms, including burning pain (especially at night), muscle wasting, paralysis, or organ or gland dysfunction. Peripheral neuropathy may be either inherited or acquired. Causes of acquired peripheral neuropathy include physical injury (trauma) to a nerve, tumors, toxins, autoimmune responses, nutritional deficiencies, alcoholism, and vascular and metabolic disorders. Acquired peripheral neuropathies are caused by systemic disease, trauma from external agents, or infections or autoimmune disorders affecting nerve tissue. Inherited forms of peripheral neuropathy are caused by inborn mistakes in the genetic code or by new genetic mutations.
Seattle Genetics announces collaboration to globally develop and commercialize brentuximab vedotin

Seattle Genetics announces collaboration to globally develop and commercialize brentuximab vedotin

Pfizer announces results from studies evaluating neratinib

Pfizer announces results from studies evaluating neratinib

University of Maryland School of Nursing to spearhead new Center for Pain Studies

University of Maryland School of Nursing to spearhead new Center for Pain Studies

VERTICAL Phase II trial results for NHL released

VERTICAL Phase II trial results for NHL released

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma

Phase 2 study of carfilzomib shows promising results in patients with refractory multiple myeloma

Encouraging data from Seattle Genetics' phase I trial of brentuximab vedotin

Encouraging data from Seattle Genetics' phase I trial of brentuximab vedotin

New three-drug combination may be effective for treating patients with bone cancer

New three-drug combination may be effective for treating patients with bone cancer

Researchers explore optimal induction therapies for managing blood cancer

Researchers explore optimal induction therapies for managing blood cancer

VELCADE based regimens are cost-effective for payers and patients, finds study

VELCADE based regimens are cost-effective for payers and patients, finds study

Updated safety data from Phase 2b 003-A1 study of carfilzomib announced

Updated safety data from Phase 2b 003-A1 study of carfilzomib announced

Tibotec Therapeutics'  INTELENCE granted FDA traditional approval

Tibotec Therapeutics' INTELENCE granted FDA traditional approval

Breast cancer patients treated with chemotherapy drug Taxol more likely to develop chronic neuropathic pain

Breast cancer patients treated with chemotherapy drug Taxol more likely to develop chronic neuropathic pain

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

Millennium commences Phase I clinical trial for its second-generation proteasome inhibitor

NeoPharm presents LE-DT Phase I data at the AACR conference

NeoPharm presents LE-DT Phase I data at the AACR conference

University of Michigan to develop novel therapy for neuropathic pain

University of Michigan to develop novel therapy for neuropathic pain

Folate-enriched prescription medical food lowers medical costs of patients with peripheral neuropathy

Folate-enriched prescription medical food lowers medical costs of patients with peripheral neuropathy

HealthCore study shows Metanx tablets reduces health plan costs

HealthCore study shows Metanx tablets reduces health plan costs

Pregabalin reduces abdominal pain and improves sleep in women with adhesions

Pregabalin reduces abdominal pain and improves sleep in women with adhesions

Testicular cancer survivors at risk of effective treatment

Testicular cancer survivors at risk of effective treatment